FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer

被引:14
|
作者
Luu, Andreas Minh [1 ]
Herzog, Torsten [1 ]
Hoehn, Philipp [1 ]
Reinacher-Schick, Anke [2 ]
Munding, Johanna [3 ]
Uhl, Waldemar [1 ]
Braumann, Chris [1 ]
机构
[1] Ruhr Univ Bochum, St Josef Hosp, Dept Gen & Visceral Surg, Gudrunstr 56, D-44791 Bochum, Germany
[2] Ruhr Univ Bochum, St Josef Hosp, Dept Oncol, Bochum, Germany
[3] Univ Hosp Bergmannsheil, Inst Pathol, Bochum, Germany
关键词
Pathologic complete response (pCR); ypT0; pancreatic cancer (PC); FOLFIRINOX; MANAGEMENT; RESECTION; OUTCOMES;
D O I
10.21037/jgo.2018.01.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer (PC) is a lethal disease with a poor prognosis. It is typically asymptomatic and therefore most often diagnosed at an advanced stage. A primary unresectable PC can become resectable in case of tumor regression turning palliative into neoadjuvant therapy. We present a 67-year old female patient who was diagnosed with a locally advanced adenocarcinoma of the pancreatic head. After receiving palliative intended chemotherapy with the FOLFIRINOX regimen, staging computed tomography revealed local resectability of the pancreatic head tumor. The patient underwent an uneventful total pancreatectomy. Pathohistological investigation revealed a pathologic complete response (pCR). pCR after FOLFIRINOX treatment in primary unresectable PC is extremely rare. It might enable surgical resection and can increase the survival rate.
引用
收藏
页码:E9 / E12
页数:4
相关论文
共 50 条
  • [41] FOLFIRINOX for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Hisai, Hiroyuki
    Tamaki, Sakurai
    Yuuki, Ikeda
    Yutaka, Koshiba
    Masafumi, Sato
    Ryosuke, Kawasaki
    Hiroshi, Gyobu
    Etsu, Miyazaki
    Tasuku, Hirako
    Shogo, Miura
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 120 - 120
  • [42] Induction FOLFIRINOX Prior to Chemoradiation for Borderline or Locally-Advanced Pancreatic Cancer
    Mancini, B. R.
    Lloyd, S.
    Lacy, J.
    Rutter, C. E.
    Chang, B. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S304 - S304
  • [43] Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
    Jalilian, Mahshid
    Davis, Sidney
    Mohebbi, Mohammadreza
    Sugamaran, Bhuvana
    Porter, Ian W.
    Bell, Stephen
    Warrier, Satish K.
    Wale, Roger
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 603 - 608
  • [44] Pathologic Response to Primary Systemic Therapy With FOLFIRINOX in Patients With Resectable Pancreatic Cancer
    Polish, Ariel
    Joseph, Nora E.
    Marsh, Robert de W.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (10): : 761 - 766
  • [45] Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer
    Golan, Talia
    Barenboim, Alex
    Lahat, Guy
    Nachmany, Ido
    Goykhman, Yacov
    Shacham-Shmueli, Einat
    Halpern, Naama
    Brazowski, Eli
    Geva, Ravit
    Wolf, Ido
    Goldes, Yuri
    Ben-Haim, Menahem
    Klausner, Joseph M.
    Lubezky, Nir
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 3963 - 3970
  • [46] Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation
    Okada, Kenjiro
    Uemura, Kenichiro
    Okamoto, Wataru
    Sumiyoshi, Tatsuaki
    Shintakuya, Ryuta
    Otsuka, Hiroyuki
    Serikawa, Masahiro
    Ishii, Yasutaka
    Arihiro, Koji
    Takahashi, Shinya
    [J]. CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (02) : 283 - 288
  • [47] Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation
    Kenjiro Okada
    Kenichiro Uemura
    Wataru Okamoto
    Tatsuaki Sumiyoshi
    Ryuta Shintakuya
    Hiroyuki Otsuka
    Masahiro Serikawa
    Yasutaka Ishii
    Koji Arihiro
    Shinya Takahashi
    [J]. Clinical Journal of Gastroenterology, 2023, 16 : 283 - 288
  • [48] Surgical Complications and Pathologic Complete Response after Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
    Duldulao, Marjun P.
    Lee, Wendy
    Le, Maithao
    Wiatrek, Rebecca
    Nelson, Rebecca A.
    Chen, Zhenbin
    Li, Wenyan
    Kim, Joseph
    Garcia-Aguilar, Julio
    [J]. AMERICAN SURGEON, 2011, 77 (10) : 1281 - 1285
  • [49] Pathologic complete response to standard preoperative chemoradiation in patients with locally advanced rectal cancer.
    Naseem, Madiha
    Murray, Joshua
    Simmons, Christine E.
    Baxter, Nancy
    Burnstein, Marcus J.
    Brezden-Masley, Christine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [50] Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer
    Al-Tweigeri, Taher
    Elshenawy, Mahmoud
    Badran, Ahmed
    Omar, Ayman
    Suleman, Kausar
    Al Malik, Osama
    Anwar, Ihab
    Jastaniya, Noha
    Tulbah, Asma
    Al Shabanah, Mohammad
    Ajarim, Dahish
    Al Sayed, Adher
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021